{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T17:53:44Z","timestamp":1767117224221,"version":"3.37.3"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,5,26]],"date-time":"2021-05-26T00:00:00Z","timestamp":1621987200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,5,26]],"date-time":"2021-05-26T00:00:00Z","timestamp":1621987200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammation"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1007\/s10753-021-01477-0","type":"journal-article","created":{"date-parts":[[2021,5,26]],"date-time":"2021-05-26T10:02:52Z","timestamp":1622023372000},"page":"2006-2017","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Downregulation of Cathepsin B Reduces Proliferation and Inflammatory Response and Facilitates Differentiation in Human HaCaT Keratinocytes, Ameliorating IL-17A and SAA-Induced Psoriasis-Like Lesion"],"prefix":"10.1007","volume":"44","author":[{"given":"Di","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2671-9254","authenticated-orcid":false,"given":"Jie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,5,26]]},"reference":[{"key":"1477_CR1","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/S0140-6736(14)61909-7","volume":"386","author":"WH Boehncke","year":"2015","unstructured":"Boehncke, W.H., and M.P. Sch\u00f6n. 2015. Psoriasis. Lancet 386: 983\u2013994.","journal-title":"Lancet"},{"key":"1477_CR2","first-page":"334","volume":"15","author":"L Stein Gold","year":"2016","unstructured":"Stein Gold, L., J.M. Jackson, M.L. Knuckles, and J.S. Weiss. 2016. Improvement in extensive moderate plaque psoriasis with a novel emollient spray formulation of betamethasone dipropionate 0.05. Journal of drugs in dermatology: JDD 15: 334\u2013342.","journal-title":"Journal of drugs in dermatology: JDD"},{"key":"1477_CR3","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/j.jid.2017.11.030","volume":"138","author":"JL Arbiser","year":"2018","unstructured":"Arbiser, J.L., and J. Elsey. 2018. Targeting the plasticity of psoriasis. The Journal of Investigative Dermatology 138: 734\u2013736.","journal-title":"The Journal of Investigative Dermatology"},{"key":"1477_CR4","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.jdermsci.2017.12.002","volume":"89","author":"L Yang","year":"2018","unstructured":"Yang, L., W. Guo, S. Zhang, and G. Wang. 2018. Ubiquitination-proteasome system: a new player in the pathogenesis of psoriasis and clinical implications. Journal of Dermatological Science 89: 219\u2013225.","journal-title":"Journal of Dermatological Science"},{"key":"1477_CR5","doi-asserted-by":"publisher","first-page":"2932","DOI":"10.1038\/s41598-020-60050-1","volume":"10","author":"HJ Li","year":"2020","unstructured":"Li, H.J., N.L. Wu, C.M. Pu, C.Y. Hsiao, D.C. Chang, and C.F. Hung. 2020. Chrysin alleviates imiquimod-induced psoriasis-like skin inflammation and reduces the release of CCL20 and antimicrobial peptides. Scientific Reports 10: 2932.","journal-title":"Scientific Reports"},{"key":"1477_CR6","doi-asserted-by":"publisher","first-page":"106751","DOI":"10.1016\/j.intimp.2020.106751","volume":"86","author":"M Liu","year":"2020","unstructured":"Liu, M., G. Zhang, S. Naqvi, F. Zhang, T. Kang, Q. Duan, Z. Wang, S. Xiao, and Y. Zheng. 2020. Cytotoxicity of Saikosaponin A targets HEKa cell through apoptosis induction by ROS accumulation and inflammation suppression via NF-\u03baB pathway. International Immunopharmacology 86: 106751.","journal-title":"International Immunopharmacology"},{"key":"1477_CR7","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1615\/JEnvironPatholToxicolOncol.2019030782","volume":"38","author":"J Ma","year":"2019","unstructured":"Ma, J., S. Feng, D. Ai, Y. Liu, and X. Yang. 2019. D-pinitol ameliorates imiquimod-induced psoriasislike skin inflammation in a mouse model via the NF-\u03baB pathway. Journal of environmental pathology, toxicology and oncology: official organ of the International Society for Environmental Toxicology and Cancer 38: 285\u2013295.","journal-title":"Journal of environmental pathology, toxicology and oncology: official organ of the International Society for Environmental Toxicology and Cancer"},{"key":"1477_CR8","doi-asserted-by":"publisher","first-page":"110696","DOI":"10.1016\/j.biopha.2020.110696","volume":"131","author":"W Zhou","year":"2020","unstructured":"Zhou, W., M. Hu, X. Zang, Q. Liu, J. Du, J. Hu, L. Zhang, Z. Du, and Z. Xiang. 2020. Luteolin attenuates imiquimod-induced psoriasis-like skin lesions in BALB\/c mice via suppression of inflammation response. Biomedicine & pharmacotherapy = Biom\u00e9decine & pharmacoth\u00e9rapie 131: 110696.","journal-title":"Biomedicine & pharmacotherapy = Biom\u00e9decine & pharmacoth\u00e9rapie"},{"key":"1477_CR9","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s11883-020-00888-y","volume":"22","author":"O Gursky","year":"2020","unstructured":"Gursky, O. 2020. Structural basis for vital function and malfunction of serum amyloid A: an acute-phase protein that wears hydrophobicity on its sleeve. Current Atherosclerosis Reports 22: 69.","journal-title":"Current Atherosclerosis Reports"},{"key":"1477_CR10","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.jid.2016.10.016","volume":"137","author":"S Morizane","year":"2017","unstructured":"Morizane, S., K. Mizuno, T. Takiguchi, S. Sugimoto, and K. Iwatsuki. 2017. The involvement of serum amyloid A in psoriatic inflammation. The Journal of Investigative Dermatology 137: 757\u2013760.","journal-title":"The Journal of Investigative Dermatology"},{"key":"1477_CR11","doi-asserted-by":"publisher","first-page":"e12764","DOI":"10.1111\/sji.12764","volume":"89","author":"M Choi","year":"2019","unstructured":"Choi, M., M.O. Kim, J. Lee, J. Jeong, Y. Sung, S. Park, W. Kwon, S. Jang, S.J. Park, H.S. Kim, W.Y. Jang, S.H. Kim, S. Lee, S.K. Choi, and Z.Y. Ryoo. 2019. Hepatic serum amyloid A1 upregulates interleukin-17 (IL-17) in \u03b3\u03b4 T cells through Toll-like receptor 2 and is associated with psoriatic symptoms in transgenic mice. Scandinavian Journal of Immunology 89: e12764.","journal-title":"Scandinavian Journal of Immunology"},{"key":"1477_CR12","doi-asserted-by":"publisher","first-page":"e12320","DOI":"10.1111\/cpr.12320","volume":"50","author":"N Yu","year":"2017","unstructured":"Yu, N., S. Zhang, J. Lu, Y. Li, X. Yi, L. Tang, L. Su, and Y. Ding. 2017. Serum amyloid A, an acute phase protein, stimulates proliferative and proinflammatory responses of keratinocytes. Cell Proliferation 50: e12320.","journal-title":"Cell Proliferation"},{"key":"1477_CR13","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1186\/s13075-019-2040-6","volume":"21","author":"Y Fujita","year":"2019","unstructured":"Fujita, Y., N. Matsuoka, J. Temmoku, M.Y. Furuya, T. Asano, S. Sato, H. Kobayashi, H. Watanabe, E. Suzuki, T. Urano, H. Kozuru, H. Yatsuhashi, T. Koga, A. Kawakami, and K. Migita. 2019. Hydroxychloroquine inhibits IL-1\u03b2 production from amyloid-stimulated human neutrophils. Arthritis Research & Therapy 21: 250.","journal-title":"Arthritis Research & Therapy"},{"key":"1477_CR14","doi-asserted-by":"publisher","first-page":"4805","DOI":"10.4049\/jimmunol.1200901","volume":"190","author":"T Hirai","year":"2013","unstructured":"Hirai, T., T. Kanda, K. Sato, M. Takaishi, K. Nakajima, M. Yamamoto, R. Kamijima, J. Digiovanni, and S. Sano. 2013. Cathepsin K is involved in development of psoriasis-like skin lesions through TLR-dependent Th17 activation. The Journal of immunology: official journal of the American Association of Immunologists 190: 4805\u20134811.","journal-title":"The Journal of immunology: official journal of the American Association of Immunologists"},{"key":"1477_CR15","doi-asserted-by":"publisher","first-page":"581","DOI":"10.2147\/DDDT.S194765","volume":"13","author":"J Guo","year":"2019","unstructured":"Guo, J., J. Tu, Y. Hu, G. Song, and Z. Yin. 2019. Cathepsin G cleaves and activates IL-36\u03b3 and promotes the inflammation of psoriasis. Drug Design, Development and Therapy 13: 581\u2013588.","journal-title":"Drug Design, Development and Therapy"},{"key":"1477_CR16","doi-asserted-by":"publisher","first-page":"3903","DOI":"10.7150\/thno.31037","volume":"9","author":"J Schwenck","year":"2019","unstructured":"Schwenck, J., A. Maurer, B. Fehrenbacher, R. Mehling, P. Knopf, N. Mucha, D. Haupt, K. Fuchs, C.M. Griessinger, D. Bukala, J. Holstein, M. Schaller, I.G. Menendez, K. Ghoreschi, L. Quintanilla-Martinez, M. G\u00fctschow, S. Laufer, T. Reinheckel, M. R\u00f6cken, H. Kalbacher, B.J. Pichler, and M. Kneilling. 2019. Cysteine-type cathepsins promote the effector phase of acute cutaneous delayed-type hypersensitivity reactions. Theranostics 9: 3903\u20133917.","journal-title":"Theranostics"},{"key":"1477_CR17","doi-asserted-by":"publisher","first-page":"4848","DOI":"10.3892\/mmr.2020.11583","volume":"22","author":"C Liu","year":"2020","unstructured":"Liu, C., Z. Cai, T. Hu, Q. Yao, and L. Zhang. 2020. Cathepsin B aggravated doxorubicin-induced myocardial injury via NF-\u03baB signalling. Molecular Medicine Reports 22: 4848\u20134856.","journal-title":"Molecular Medicine Reports"},{"key":"1477_CR18","doi-asserted-by":"publisher","first-page":"288","DOI":"10.3389\/fimmu.2012.00288","volume":"3","author":"CD Savage","year":"2012","unstructured":"Savage, C.D., G. Lopez-Castejon, A. Denes, and D. Brough. 2012. NLRP3-inflammasome activating DAMPs stimulate an inflammatory response in glia in the absence of priming which contributes to brain inflammation after injury. Frontiers in Immunology 3: 288.","journal-title":"Frontiers in Immunology"},{"key":"1477_CR19","doi-asserted-by":"publisher","first-page":"9465","DOI":"10.1523\/JNEUROSCI.0801-19.2019","volume":"39","author":"J Yu","year":"2019","unstructured":"Yu, J., H. Zhu, S. Taheri, W. Mondy, L. Bonilha, G.S. Magwood, D. Lackland, R.J. Adams, and M.S. Kindy. 2019. Serum amyloid A-mediated inflammasome activation of microglial cells in cerebral ischemia. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience 39: 9465\u20139476.","journal-title":"The Journal of Neuroscience: The Official Journal of the Society for Neuroscience"},{"key":"1477_CR20","doi-asserted-by":"publisher","first-page":"631","DOI":"10.3892\/etm.2015.2939","volume":"11","author":"WY Ma","year":"2016","unstructured":"Ma, W.Y., K. Jia, and Y. Zhang. 2016. IL-17 promotes keratinocyte proliferation via the downregulation of C\/EBP\u03b1. Experimental and Therapeutic Medicine 11: 631\u2013636.","journal-title":"Experimental and Therapeutic Medicine"},{"key":"1477_CR21","doi-asserted-by":"publisher","first-page":"105","DOI":"10.3390\/ijms20010105","volume":"20","author":"A Vallejo","year":"2018","unstructured":"Vallejo, A., B. Chami, J.M. Dennis, M. Simone, G. Ahmad, A.I. Abdo, A. Sharma, W.A. Shihata, N. Martin, J. Chin-Dusting, J.B. de Haan, and P.K. Witting. 2018. NF\u03baB inhibition mitigates serum amyloid A-induced pro-atherogenic responses in endothelial cells and leukocyte adhesion and adverse changes to endothelium function in isolated aorta. International Journal of Molecular Sciences 20: 105.","journal-title":"International Journal of Molecular Sciences"},{"key":"1477_CR22","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak, K.J., and T.D. Schmittgen. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods: a companion to Methods in enzymology 25: 402\u2013408.","journal-title":"Methods: a companion to Methods in enzymology"},{"key":"1477_CR23","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.autrev.2016.09.015","volume":"16","author":"LI Sakkas","year":"2017","unstructured":"Sakkas, L.I., and D.P. Bogdanos. 2017. Are psoriasis and psoriatic arthritis the same disease? The IL-23\/IL-17 axis data. Autoimmunity Reviews 16: 10\u201315.","journal-title":"Autoimmunity Reviews"},{"key":"1477_CR24","first-page":"2715","volume":"22","author":"L Zhuang","year":"2020","unstructured":"Zhuang, L., W. Ma, J. Yan, and H. Zhong. 2020. Evaluation of the effects of IL-22 on the proliferation and differentiation of keratinocytes in vitro. Molecular Medicine Reports 22: 2715\u20132722.","journal-title":"Molecular Medicine Reports"},{"key":"1477_CR25","doi-asserted-by":"crossref","unstructured":"Abe, S., M. Ueno, M. Nishitani, T. Akamatsu, T. Sato, M. Shimoda, H. Kanaoka, Y. Nii, H. Yamasaki, and K. Yuasa. 2020. Citrus sudachi peel extract suppresses cell proliferation and promotes the differentiation of keratinocytes through inhibition of the EGFR-ERK signaling pathway. Biomolecules 10.","DOI":"10.3390\/biom10101468"},{"key":"1477_CR26","first-page":"254","volume":"111","author":"C Sun","year":"2020","unstructured":"Sun, C., and J. Xia. 2020. Treatment of psoriasis: janus kinases inhibitors and biologics for the interleukin-23\/Th17 axis. Minerva Medica 111: 254\u2013265.","journal-title":"Minerva Medica"},{"key":"1477_CR27","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3892\/etm.2020.9480","volume":"21","author":"J Zhang","year":"2021","unstructured":"Zhang, J., J. Zhang, Q. Lin, L. Chen, and Y. Song. 2021. IL-17 promotes proliferation, inflammation and inhibits apoptosis of HaCaT cells via interacting with the TRAF3 interacting protein 2. Experimental and Therapeutic Medicine 21: 49.","journal-title":"Experimental and Therapeutic Medicine"},{"key":"1477_CR28","doi-asserted-by":"publisher","first-page":"e0205340","DOI":"10.1371\/journal.pone.0205340","volume":"13","author":"J Chorachoo","year":"2018","unstructured":"Chorachoo, J., S. Lambert, T. Furnholm, L. Roberts, L. Reingold, S. Auepemkiate, S.P. Voravuthikunchai, and A. Johnston. 2018. The small molecule rhodomyrtone suppresses TNF-\u03b1 and IL-17A-induced keratinocyte inflammatory responses: a potential new therapeutic for psoriasis. PLoS One 13: e0205340.","journal-title":"PLoS One"},{"key":"1477_CR29","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1111\/cei.12458","volume":"179","author":"N Yu","year":"2015","unstructured":"Yu, N., S. Liu, X. Yi, S. Zhang, and Y. Ding. 2015. Serum amyloid A induces interleukin-1\u03b2 secretion from keratinocytes via the NACHT, LRR and PYD domains-containing protein 3 inflammasome. Clinical and Experimental Immunology 179: 344\u2013353.","journal-title":"Clinical and Experimental Immunology"},{"key":"1477_CR30","doi-asserted-by":"publisher","first-page":"e0181486","DOI":"10.1371\/journal.pone.0181486","volume":"12","author":"E Couderc","year":"2017","unstructured":"Couderc, E., F. Morel, P. Levillain, A. Buffi\u00e8re-Morgado, M. Camus, C. Paquier, C. Bodet, J.F. J\u00e9gou, M. Pohin, L. Favot, M. Garcia, V. Huguier, J. Mcheik, C. Lacombe, H. Yssel, G. Guillet, F.X. Bernard, and J.C. Lecron. 2017. Interleukin-17A-induced production of acute serum amyloid A by keratinocytes contributes to psoriasis pathogenesis. PLoS One 12: e0181486.","journal-title":"PLoS One"}],"container-title":["Inflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-021-01477-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10753-021-01477-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-021-01477-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,23]],"date-time":"2021-09-23T06:59:05Z","timestamp":1632380345000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10753-021-01477-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,26]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["1477"],"URL":"https:\/\/doi.org\/10.1007\/s10753-021-01477-0","relation":{},"ISSN":["0360-3997","1573-2576"],"issn-type":[{"type":"print","value":"0360-3997"},{"type":"electronic","value":"1573-2576"}],"subject":[],"published":{"date-parts":[[2021,5,26]]},"assertion":[{"value":"28 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interests"}}]}}